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Abstract 
 
The potential for maternal nanoparticle exposures to cause developmental toxicity in the fetus 
without the passage of nanoparticles has previously been shown. We now demonstrate that 
exposure of CoCr nanoparticles to BeWo cell barriers, a human in vitro model of the human 
placenta, triggers an impairment of autophagic flux and the release of the proinflammatory factor 
IL-6. This contributes to an altered differentiation of human neuroprogenitor cells plus DNA 
damage in the derived neurons and astrocytes that is mediated by the astrocytes. Inhibiting 
autophagic degradation in the BeWo barrier by overexpression of a dominant-negative human 
ATG4BC74A significantly reduces the levels of DNA damage in astrocytes. In vivo, indirect 
nanoparticle toxicity in mice also results in neurodevelopmental abnormalities with reactive 
astrogliosis and increased DNA damage in the fetal hippocampus. This demonstrates the potential 
importance of autophagy in eliciting nanoparticle toxicity and the risk of indirect developmental 
neurotoxicity following maternal nanoparticle exposure.   
 
Article 
 
Nanoparticles (NPs) are being increasingly used in drug delivery, chemotherapy, imaging and 
diagnostics due to their ability to travel within organisms by utilising cellular pathways (Anselmo 
and Mitragotri, 2016). During their interactions with cell membranes, and internalisation into cells, 
key signalling pathways and processes are altered (Saei et al., 2017). In addition to affecting the 
health of directly exposed cells, the internalization of NPs can also detrimentally affect 
neighbouring cells in a manner similar to the radiation induced bystander effect (Thubagere and 
Reinhard, 2010).  
In bilayered BeWo in vitro models of the placental barrier it has been shown that biopersistent NPs 
are internalised into the upper trophoblast cell layer triggering intercellular signalling (Bhabra et al., 
2009; Sood et al., 2011). The exposed barriers undergo increased Connexin-43 (CX43) dependent 
signalling that leads to the secretion of factors such as ATP. These factors can then detrimentally 
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affect fibroblasts and differentiating human Embryonic Stem (hES) cells remote from this barrier. 
This “indirect” toxicity does not occur when single layered barriers are exposed to NPs and is not 
due to the passage of the degradation products of NPs. In pregnant mice exposure to CoCr NPs at 
E12.5 also causes increased levels of DNA damage in the blood and livers of their progeny without 
NPs crossing the placenta (Sood et al., 2011).  
 
The most common developmental abnormalities in humans due to the maternal exposure to toxins, 
relate to neurodevelopment (Grandjean and Landrigan, 2014). Studies have shown this is also 
likely the situation for biopersistent NP exposures during pregnancy (Shimizu et al., 2009; 
Hougaard et al., 2010; Mohammadipour et al., 2014). It has been found that NPs can cause 
reduced cell proliferation in the fetal hippocampus, impaired learning and memory 
(Mohammadipour et al., 2014), altered expression of genes related to brain development (Shimizu 
et al., 2009), and neurobehavioural abnormalities (Hougaard et al., 2010). These changes have 
been considered to occur due to the transfer of NPs or their degradation products across the 
placenta to the fetus (Mohammadipour et al., 2014). It has, however, been shown that NPs can 
cause intrauterine growth restriction (Yamashita et al., 2011) and developmental abnormalities 
without crossing the placenta (Sood et al., 2011). The importance of the placenta for fetal brain 
development has also been shown (Goeden et al., 2016). 
 
Here we show that the signalling cascade, triggered by biopersistent NPs in the BeWo model of 
the placenta and involving the cytokine IL-6, causes DNA damage in differentiating neural 
progenitor cells. The initiation of this signal is mediated by autophagy while the resulting DNA 
damage in neurons is dependent on the presence of astrocytes. Inhibiting the autophagy response 
to the application of NPs in the BeWo barrier, by lentiviral transduction with dominant-negative 
human ATG4BC74A, significantly reduces the levels of DNA damage in astrocytes. Finally in vivo, 
we demonstrate that maternal NP exposure at E12.5 results in reactive astrogliosis and increased 
DNA damage in the neonatal hippocampus.  
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Results 
 
CoCr NPs alter autophagic flux in BeWo models of the placenta. 
 
BeWo cells, a human trophoblast choriocarcinoma derived cell line, were grown on transwell 
inserts for 7 days so as to form confluent bilayered cell barriers (Figure 1a) (Bhabra et al., 2009). 
BeWo cell barriers are widely used as in vitro models of the placental barrier to study placental 
endocrine function and transplacental transport of substances such as drugs, amino acids, 
immunoglobulins, fatty acids, transferrin and viruses (Li et al., 2013; Bode et al., 2006). These cells 
were exposed to NPs of cobalt and chromium (CoCr) surgical alloy, as humans are exposed 
internally to CoCr nanoparticles by wear mechanisms associated with metal-on-metal (CoCr) 
orthopaedic joint replacement (Polyzois et al., 2012). CoCr NPs are known to have genotoxic and 
cytotoxic effects in human tissue culture if they are added directly to cells in culture (Papageorgiou 
et al., 2007). However, when BeWo barriers are exposed to a low concentration of CoCr NPs (0.04 
mg/ml) the barriers remain intact, shown by unaltered trans epithelial electric resistance (TEER) 
measurements (Figure 1b), and NPs fail to traverse to the basolateral milieu (Bhabra et al., 2009; 
Sood et al., 2011 ). Instead, the NPs are internalised into the upper layer of the barriers, triggering 
an increased barrier stress response characterised by the impairment of mitochondrial activity (See 
Fig S1). A DNA damaging signal is transmitted from the barrier that results in greater levels of DNA 
damage in exposed cells than if the same amount of NPs were exposed to the cells directly 
(Bhabra et al., 2009; Sood et al., 2011).  
 
We now show that P53 expression levels are elevated in NP-treated barriers, whereas HSP70 
expression remains unaffected (Figure 1c & d). As mitochondrial inhibition due to oxidative stress 
has been shown to induce autophagy via p53 (Crighton et al., 2006), the levels of autophagic 
activity were also determined. Western blot analysis revealed increased protein expression for 
LC3-II and P62 indicating a build up of autophagosomes associated with a blockade of 
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autophagosome clearance (Figure 1c, e & f) (Klionsky et al., 2016). This was found to occur 
predominantly in the upper layer of the barrier where NPs accumulate following internalisation 
(Figure 1j & k) (Sood et al., 2011. When the lysosomal blocker bafilomycin A1 (Klionsky et al., 
2016) was added (Figure 1i & l), an increase in LC3 positive puncta and P62 staining intensity was 
recorded upon barrier immunostaining (Fig 1g - l). NP exposure therefore results in altered 
autophagic flux, with a partial blockade of autophagosomal clearance likely due to impaired 
lysosomal function, in a similar fashion to the effects of gold and polystyrene NPs (Ma et al., 2011). 
 
Indirect NP exposure causes DNA damage in human astrocytes and neurons. 
 
To investigate the effect of the DNA damaging signalling on neural cell lineage differentiation, 
media was conditioned under the BeWo barrier during NP exposure then transferred onto 
differentiating NPCs (See Figure S2). These were derived from the human fetal cortex and 
differentiated in culture to form neurons and astrocytes (See Figure S3a) (Svendsen et al., 1998). 
Results showed that exposure to conditioned media had no effect on cell survival (See Figure S4); 
however, immunostaining revealed a phenotypic shift towards glial cell differentiation (See Figure 
S3b). These glial cells were immunostained with GFAP and their astrocyte identity was confirmed 
by co-staining with EAAT1 (See Figure S5). A marked change in the morphology of the astrocytes 
was also seen, evidenced by increased nuclear and cytoplasmic areas (Figure 2a-f). The neurons 
in culture with the astrocytes did not show obvious morphological changes (data not shown). The 
phenotypic changes found in the astrocytes suggest that they may have become reactive; although 
qPCR analysis revealed similar expression levels of GFAP compared to the barrier control (See 
Figure S6 ( Sofroniew, 2014).  
 
The changes found in astrocytes were not due to oxidative stress (See Figure S4b); therefore we 
looked for evidence of astrocytic DNA damage responses. γ-H2AX immunostaining was performed 
to identify double stranded DNA breaks in neuronal/astrocytic cultures co-stained for either TUJ1 
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or GFAP (Dickey et al., 2009). When a double stranded DNA break occurs, H2A histone family 
member X (H2AX), becomes extensively phosphorylated at serine -129, and forms foci at break 
sites referred to as γ-H2AX foci (Paull et al., 2000). Immunostaining for γ-H2AX revealed an 
increase in the numbers of γ-H2AX foci in our exposure group in both astrocytes and neurons, but 
with a more pronounced affect in astrocytes (Figure 3a, c) than in neurons (Figure 3b, d and e). 
Increased γ-H2AX foci formation in astrocytes also occurred following barrier exposure to 
0.04mg/ml TiO2 NPs (See Figure S7). However exposure to 5% [w/v] F127 NPs, which are under 
investigation for drug delivery to the brain, did not induce the same increase in astrocyte γ-H2AX 
foci (See Figure S8) (Yamashita et al., 2011; Sood et al., 2011; Basak and Bandyopadhyay, 2013). 
 
The formation of γ-H2AX foci in neurons dependson astrocytes. 
 
Investigations were next performed to determine whether the astrocytes might be influencing any 
toxic effect on the neurons in culture. An established mechanism by which astrocytes mediate 
neuroprotection is by the production of glutathione (GSH) (Chen et al., 2001). GSH-glo assay 
assessment demonstrated a large increase in GSH in the culture medium (See Figure S9); 
however, when primary cultures that were characterised as >99% neuronal (see Figure 4a) were 
exposed, only low background levels of γ-H2AX foci were detected in neurons, with no difference 
in comparison to controls (Figure 4b). Also, when an additional stage of media conditioning was 
introduced – in which the media was first placed onto cultures of astrocytes derived from human 
neural progenitors – increased levels of DNA damage were once again observed in primary 
neurons (Figure 4c). We therefore concluded that the formation of γ-H2AX foci in the primary 
neurons was dependent on the presence of astrocytes in culture. 
 
As astrocytes appear later in embryonic development than neurons, we next investigated whether 
the indirect toxicity we observed was a stage specific effect only occurring once astrocytes have 
differentiated (Barnabe-Heider et al., 2005). To test this we utilised a hES cell line to generate the 
primitive germ layers, including the neuroectoderm as occurs in the very early embryo (Pal et al., 
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2011). An embryoid body (EB) model was used to induce germ layer differentiation and we 
examined expression of P53 by qPCR (Pal et al., 2011). No increase in the expression of P53 was 
observed which suggests that at this early stage of differentiation there is no activation of DNA 
damage pathways (Figure 4d). Furthermore no difference was found in the expression of the 
neuroectoderm markers NESTIN or SOX1 during gene expression profiling (Figure 4d), or flow 
cytometry assessment (See Figure S10), indicating that exposure to BeWo conditioned media in 
the presence of NPs does not affect early neural differentiation (Pevny et al., 1998). 
 
DNA damaging signalling and initialisation in the BeWo barrier 
 
Further experiments were performed to try to further establish the mechanism by which the DNA 
damaging signalling is communicated to astrocytes. In Sood et al., it was believed that the 
signalling was transmitted via a burst of ATP from the barrier plus an additional vesicular release of 
protein (Sood et al., 2011). As ATP was unlikely to have an ongoing effect past the initial 
application of conditioned media to NPCs, we examined the release of a number of 
chemokines/cytokines, namely, RANTES, GM-CSF, TNFα and IL-6, using enzyme-linked 
immunosorbent assays. ELISAs were performed on media conditioned by the BeWo barrier and 
also from astrocytes that had been exposed to media from the BeWo barrier. TNFα and IL-6 were 
found to be secreted by the BeWo barrier; however, RANTES and GM-CSF were below the limit of 
detection. TNFαsecretion did not increase following exposure of the BeWo barrier to NPs, or 
following culture of NPC derived astrocytes (See Figure S11). IL-6 secretion from the BeWo barrier 
following NP exposure did however significantly increase (See Figure S12), and remained 
significantly elevated following culture of NPC derived astrocytes (Figure 4e). The role of IL-6 in the 
initiation of DNA damage was further investigated by transducing the BeWo barrier with two 
different lentiviral vectors expressing an IL-6 Sh-RNA. TEER measurements confirmed barrier 
integrity post lentivirus and CoCr NP exposure (See Figure S13). IL-6 reduction was confirmed by 
ELISA (See Figure S14), media was transferred onto differentiating NPC’s and γ-H2AX 
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immunostaining was performed. Significantly reduced levels of γ-H2AX were recorded in GFAP 
positive astrocytes (Figure 4f). exposed to media from barriers treated with Sh-IL-6 and GFAP 
negative cells (See Figure S15). In order to obtain further confirmation of the role of IL-6 we utilised 
an IL-6 blocking antibody with relevant isotype (IgG) control and obtained similar results (Figure 
4g); blockade of IL-6 was confirmed by ELISA (See Figure S16). Interestingly a medium mediated 
DNA damage repair response, following ionizing radiation, has been correlated with the release of 
cytokines such as IL-6 in human fibroblasts (Dieriks et al., 2010). 
 
The role of autophagy in the initiation of the DNA damage was then further investigated by 
transducing the BeWo barrier with a lentiviral vector expressing dominant-negative human GFP-
ATG4BC74A (Fujita et al., 2008; Betin et al., 2013). ATG4B is the major ATG4 family protease 
required for priming and subsequent delipidation of ATG8 paralogues, including LC3. ATG4BC74A 
overexpression hampers LC3 lipidation and inhibits autophagic degradation due to defective 
autophagosome closure (Fujita et al., 2008). Lentiviral uptake was confirmed using confocal 
microscopy for GFP in the BeWo barriers and TEER measurements confirmed barrier integrity post 
CoCr NP exposure (See Figure S17). Media was then transferred onto differentiating NPCs and γ-
H2AX immunostaining was performed on the astrocytes in culture. Significantly reduced levels of 
γ-H2AX foci were recorded in astrocytes exposed to media from autophagy-impaired barriers, 
indicating that autophagy has a key role in the initialisation of the DNA damaging signalling (Figure 
4h).  
 
To begin to understand the possible links between autophagy and DNA damage signalling in our 
barrier model, we measured IL-6 levels in media derived from autophagy-impaired barriers treated 
with NPs (See Figure S18 & S19). Autophagic activity has previously been linked to the IL-6 
biosynthetic pathway (Maycotte et al., 2015) where a novel mTOR-enriched autolysosomal 
compartment has been implicated in the control of IL-6 secretion in diverse cellular systems (Narita 
et al., 2011). Our ELISA data revealed that barriers exposed to NPs in the presence of ATG4BC74A 
released less IL-6 than control GFP-expressing barriers (See Figure S18); a finding consistent with 
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the requirement for autophagy during IL-6 release in an airway epithelial model of ultrafine particle-
induced inflammation (Chen et al., 2016). Barriers treated with BafA1 also secreted significantly 
less IL-6 than control treated barriers in the absence and presence of NPs (See Figure S19). 
These data support a model in which the impaired, but not wholly inhibited autophagic flux activity 
seen in barriers treated with NPs, promotes the robust IL-6 release that we have recorded.  
 
IL-6 is a keystone cytokine in health and disease (Hunter and Jones, 2015). Anti-IL6 therapies are 
used to treat inflammatory conditions such as rheumatoid arthritis and have been investigated to 
treat various cancers (Mauer et al., 2015). In the nervous system IL-6 has been shown to be a 
broad mediator of neuroinflammation and is thought to have a role in the generation of reactive 
astrocytes (Campbell et al., 1993) However, it also has important roles in maintaining neural health 
including being a required signalling component of astrocyte neuroprotective effects in various 
CNS insults (Shinozaki et al., 2017; Haroon et al., 2011; Drogemuller et al., 2008). In our 
experimental conditions, IL-6 contributes to a neurotoxic effect rather than a neuroprotective effect, 
emphasising how the versatile role of IL-6 in neural health and disease requires further 
investigation (Rothaug et al., 2016). 
 
Nanoparticle exposure results in fetal neurodevelopmental abnormalities. 
 
In vivo exposures to NPs were then performed in pregnant mice to assess the potential for NPs to 
indirectly cause developmental neurotoxicity as previously described (Sood et al., 2011). Mice 
were intravenously injected with CoCr nanoparticles at two stages of pregnancy: 9.5 days, when 
the exchange of nutrients is performed by the uterus and yolk sac; and 12.5 days, when the 
placenta is fully established with three layers (Simmons et al., 2008). In our original experiments 
significant levels of Co and Cr did not increase in the neonates, nor were any pathological changes 
noted in the placenta or in the neonates visceral organs; however, increased DNA damage was 
found in neonatal blood and liver (Sood et al., 2011). Here, we analysed a number of astrocytic 
genes in whole brain samples that have previously been shown to be upregulated in astrocytes in 
	 10	
response to stress/injury (Hennessy et al., 2015; Liddelow et al., 2017; Zamanian et al., 2012). 
GFAP expression, which is increased by astrocytes in response to neurological insults (Sofroniew, 
2014), was significantly increased in the E12.5 NPs-injected group when compared to all other 
groups (CoCr effect: F  = 6.120; P=0.030.01 and embryonic age effect: F = 5.409; P = 0.048) 
(Figure 5a). In contrast, no differences in GFAP expression were recorded in the E9.5 NPs-injected 
group, highlighting the stage-specific affects of NP exposure during pregnancy. Expression of the 
astrocytic activation markers STEAP4 and PTX3 (Hennessy et al., 2015) however did not alter 
significantly at either time-point of NP exposure in whole brain when compared to relevant control 
groups (See Figure S20).  
 
Given that GFAP mRNA levels were increased, we next carried out immunohistochemical staining 
for this marker. Results showed that there was a significant increase in GFAP immunostaining in 
the hippocampus when NPs were injected at E12.5 (Figure 5b-d), as well as elevated STEAP4 
mRNA levels (Figure 5e) though not PTX3 (See Figure 21). Immunohistological staining of the 
hippocampus in the E12.5 treated animals also identified significantly increased γ -H2AX foci 
(CoCr effect: F = 14.13; P=0.0032 and embryonic age effect: F = 5.878; P=0.0337; (Figure 5f & 
See Figure S22).  
 
In summary we have shown the importance of autophagy in nanoparticle pathogenesis and that 
biopersistent NPs can cause developmental neurotoxicity across placental barriers. We have 
shown that astrocytes are key mediators of this neurotoxicity and that the fetal hippocampus is 
particularly affected in mice in vivo. 
 
Discussion 
 
The placenta is the vital support unit for the fetus and has an essential role in modulating fetal 
brain development (Muller et al., 2017; Goeden et al., 2016). 
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During periods of stress due to food deprivation, autophagy may be upregulated in the placenta to 
protect the fetal brain (Broad and Keverne, 2011). However, dysfunction of autophagy within the 
placenta is also linked to conditions such as intra-uterine growth restriction and neonatal 
encephalopathy (Avagliano et al., 2013). The autophagic and endo-lysosomal pathways are 
frequently altered by NP exposure to cells (Stern et al., 2012), exposure of CoCr NP to the BeWo 
trophoblast barriers caused autophagy dysfunction and triggered the release of IL-6. Inhibiting 
autophagic degradation in the BeWo barrier, by performing a transduction of a lentiviral vector 
containing human ATG4BC74A, significantly reduced levels of DNA damage in astrocytes. These 
results suggest that dysfunctions of autophagic pathways may be important for the initiation of NP 
induced DNA damaging signalling in BeWo trophoblast barriers.  
 
We also show that the astrocytes in exposed cultures did not provide neuroprotection to neurons 
and were instead neurotoxic. Furthermore, in vivo maternal NP exposure resulted in reactive 
astrogliosis and increased DNA damage in the neonatal hippocampus. The role of astrocytes in 
disease is increasingly becoming evident, they modify neuronal activity as part of the tripartite 
synapse, but can also cause neurotoxicity and may be involved in neurodegenerative conditions 
and epilepsy (Sofroniew, 2014). During development astrocytes and neurons have specific 
neuroglial signalling that is important for the promotion of synaptogenesis and neuronal network 
remodelling (Sun et al., 2013). We postulate that exposure of the human placenta to biopersistent 
NPs could initiate a signalling cascade, that perturbs the important relationship between astrocytes 
and neurons during neurodevelopment. We therefore argue that maternal NP exposure during 
pregnancy should if possible be avoided, even if the NPs themselves are not thought to cross the 
placenta to the fetus.  
 
Materials and methods  
 
Barrier model setup 
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BeWo cells were grown on transwell inserts for 7 days to form confluent bilayered layers of the 
cells (Figure 1a). BeWo b30 cells were obtained from Dr Margaret Saunders (University Hospitals 
Bristol NHS Foundation Trust, Bristol, UK) with permission from Dr Alan Schwartz (Washington 
University St. Louis, MO). This cell line was authenticated by the European Cell and Culture 
Collection and were tested every two months for mycoplasma contamination. Cells were cultured in 
Dulbecco’s Modified Eagle’s Nutrient Mixture (DMEM) F-12 Ham with phenol red and 
supplemented with 1% L-Glutamine-Penicillin-Streptomycin, 1% amphotericin B solution and 10% 
Fetal Bovine Serum (Sigma-Aldrich) in a humidified incubator at 37oC in 5% CO2. They were 
seeded at 105 cells/cm2 on polyester 0.4μm pore membranes on a Transwell® insert (Appleton 
Woods, Birmingham, UK) and grown for 7 days during which they had regular media changes 
(Bode et al., 2006). After 7 days they form a confluent barrier of 2-3 cells in thickness at which 
point the CoCr NPs are applied in serum free media above the barrier for 24 hours. During this the 
NPs are internalised into the upper layer of the BeWo barrier (Bhabra et al., 2009). Tissue culture 
media is conditioned below the barrier in the basal chamber during this period and is subsequently 
used in media transfer experiments (Suppl Fig 2). Serum is omitted from the NP media due to the 
potential for it to transfer to the basal chamber (Bhabra et al., 2009), as it is known to drive neural 
progenitor cell differentiation to a glial lineage (Ostenfeld and Svendsen, 2003). The integrity of the 
barrier before and after application of NPs was confirmed using Trans-Endothelial Electrical 
Resistance (TEER) measurements using an EVOM volt-ohmmeter with a 12mm Endohm unit.  
 
Lentiviral inhibition of autophagy 
Lentiviral vectors containing human ATG4BC74A with an N-terminal GFP tag or GFP alone were 
produced in pxlg3-gfp (a modified pSEW sin vector kindly provided by Dr G. Cory, University of 
Exeter) (Fujita et al., 2008; Betin et al., 2013). Lentiviruses were generated by co-transfection with 
the envelope plasmid pMD.G and the packaging plasmid pCMVR8.91 in HEK 293T cells (Danson 
et al., 2007). 
 
Preparation of nanoparticles 
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The 80 ± 14.6 nm CoCr NPs were produced by a thermal plasma method (Suppl methods and 
Suppl Table 1). Prior to use they were sonicated using a Sonics VibraCELL VC130PB sonicator 
after which they were applied to the upper chamber of the barrier model at a concentration of 
0.04mg/ml. This exposure level has previously been found not to cause transition of CoCr NPs 
across the BeWo barrier (Bhabra et al., 2009; Sood et al., 2011).  
 
Human neural progenitor cell culture 
Human fetal cortical neural progenitor cells (NPCs) were derived from 8-12 week human fetuses 
following elective termination of pregnancy under ultrasound guidance in accordance with the 
Polkinghorne and Department of Health guidelines, with full ethical committee approval and under 
the Cardiff University Human Tissue Act 2004 research licence. NPCs cells were cultured in poly-
HEMA coated tissue culture flasks in a non-adherent fashion as neurospheres and passaged, by 
chopping using a Mcllwain tissue chopper set to an interval of 200μm every 10 days as we have 
previously described (Svendsen et al., 1998). They were cultured in media composed of DMEM 
and F 12 glutamax (7:3 ratio) with 0.7% glutamax, 1% penicillin-streptomycin, 2% B27 (sigma) and 
1:1000 FGF2, 1:1000 EGF and 1:1000 Heparin (Peprotech). To study the effects on NPC 
differentiation from the conditioned media neurospheres were dissociated using accutase (Sigma) 
then placed in media without mitogens. 105 cells were then seeded onto 13mm PDL/laminin coated 
glass coverslips and allowed to adhere for 24 hours after which their media was replaced with NPC 
differentiation media conditioned in the BeWo barrier model then cultured until day 7 of 
differentiation.  
 
hES cell culture and formation of embryoid bodies 
Shef 3 hES cells were obtained under licence from the UK stem cell bank and cultured on 
mitotically inactivated Mouse Embryonic Fibroblasts. Cells were maintained in Knock Out-DMEM, 
20% Knock-out Serum Replacer (KSR), 1% NEAA, 2 mM Glutamax, 0.1 mM ß-Mercaptoethanol, 
and 1% penicillin and streptomycin (Life Technologies) supplemented with 10 ng/ml FGF2 
(Peprotech). The cells were passaged manually. EBs were formed by detaching 25 
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undifferentiated colonies from 8 hES cells plates by applying 1mg/ml Collagenase IV (Life 
Technologies) for 30 minutes at 37°C. Once detached the colonies were washed in DPBS then 
chopped into 200μm uniform pieces using McIlwain tissue chopper (Mickle Engineering, Gomshall, 
U.K.). They were then placed in Poly-HEMA coated flasks (Sigma) to prevent cell attachment and 
re-suspended in media without FGF2. These hES cell colony pieces were allowed to differentiate in 
non-adherent culture for 4 days until they had developed into spheres known as EBs. At this stage 
the EBs were removed from their media and placed in EB media that had been conditioned 
beneath the BeWo barrier. The EBs were removed from this media on day 7 then total RNA was 
extracted.  
 
In vivo experiments. 
The Seton Hall University Institutional Animal Care and Use Committee approved animal 
experiments. Adult mice (C57Bl/6; 8 weeks old) were maintained in 12h light/dark cycles with free 
access to food and water. Female mice were mated with male mice overnight and pregnant 
females were designated embryonic day 0.5 (E0.5) by the presence of a vaginal plug the next 
morning. Pregnant females were randomly selected and CoCr NPs were injected intravenously 
into their jugular vein at either E9.5 or E12.5 in 100µl of sterile saline at a dose of 0.12mg per 
mouse. Controls mice were injected with sterile saline only on either E9.5 or E12.5. Newborn pups 
(postnatal day zero, P0) were anesthetized with isoforane in a small chamber, transferred to a 
sterile petri dish and placed on a frozen ice-pack. The heart was rapidly exposed and pups 
transcardially perfused with 2ml of DepC treated phosphate buffered saline (PBS). Half of the pups 
then had their brains removed and immediately immersed in RNA later, the other half were 
transcardially perfused with 5 ml of paraformaldehyde (4%, made with DepC treated PBS). The 
brains of PFA perfused pups were also removed and placed in PFA for 24 hours then stored in 
PBS until used. Brains were cryoprotected by immersing in 30% sucrose then sectioned at 20μm 
and stored at -80oC until further analysis; a minimum of 3-4 brains were sectioned per treatment 
group. 
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γ-H2AX immunostaining assessment of DNA breaks 
Immunostaining for γ-H2AX foci was used to identify double stranded DNA breaks in NPC cells 
(Paull et al., 2000; Dickey et al., 2009). This was detected by immunocytochemistry labelling using 
rabbit anti phosphorylated H2A.X (Ser139) (Cell Signalling Technology, ♯9718) 1:500 primary 
antibody. 100 cells were imaged per biological replicate using an Olympus BX-41 microscope with 
ISIS capturing and analysing system (Metasystems). Greater than 4 foci were taken as a measure 
of significant DNA damage in keeping with accepted protocols (Sood et al., 2011; Bhabra et al., 
2009). 
 
Statistical analysis 
Statistical analysis was performed using one-way followed by Newman Keuls post hoc test or a 
two-way ANOVA with Bonferroni post hoc test for multiple comparisons or unpaired T tests (two 
tailed) with Graphpad prism statistical software. 
 
Please see supplementary section for further methods. 
 
Data availability: The data that support the findings of this study are available form the 
corresponding author upon reasonable request.  
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Figure Legends 
 
Figure 1: NPs alter autophagic flux in the upper layers of the BeWo barrier. 
(a) BeWo barrier schematic. In the apical chamber BeWo cells are cultured on a transwell insert. 
NPs are then added apically, and the barrier assessed for autophagy markers 24 hours later (b) 
Mean TEER values of BeWo barriers demonstrating that TEER measurements are not affected by 
NP exposure. P = 0.2120; unpaired t-test, two-tailed (c) Immunoblots demonstrating the expression 
of stress induced autophagy markers (P53; LC3; P62), following NP exposure. n = 3 independent 
experiments. d-f, Normalised protein expression of: (d) P53, (e) lipidated LC3-II, (f) P62 All values 
are means + SEM from three independent experiments. Unpaired t-test, two-tailed. P values are = 
0.0131 (d), 0.0209 (e) and 0.0183 (f). (g–l) Confocal immunocytochemistry for autophagy markers 
demonstrating increased LC3-positive puncta and staining intensity of P62 following exposure to 
NPs. (g-i) Upper layer of BeWo barrier (j-l) cross sectional images with the NP contact layer 
uppermost. B = barrier control, BN = barrier & NPs, BN+baf = BN & bafilomycin A1. Representative 
images from three independent experiments. Scale bars represent 30 μm.  
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Figure 2: Astrocytes in mixed NPC culture undergo morphological changes following 
indirect exposure to NPs. (a-c) Representative images from three independent experiments 
showing immunostaining of GFAP in astrocytes for control (C), barrier (B) and barrier plus NPs 
(BN). Scale bars = 20 μm. (d-f) Plots showing astrocyte morphology in each condition (d, nuclear 
area, e, nuclear versus cytoplamic area, f, cytoplasmic area). d & f, 5th to 95th percentile box and 
whisker plots, and individual data outliers, showing astrocyte nuclear and cytoplasmic areas with 
statistical analysis performed on the means from three independent experiments by one way 
ANOVA, with Newman Keuls post hoc test. (d. F=29, P =0.0008, f. F=25 P=0.0013). e, Scatter plot 
showing all data points 
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Figure 3: NPs increase the number of γ-H2AX foci in mixed astrocyte and neuronal 
cultures. 
Immunostaining for γ-H2AX with: (a) GFAP+ve astrocytes and (b) TUJ1+ve neurons, scale bar = 
10 μm. Representative images from three independent experiments. Graphs showing the 
percentage of: (c) astrocytes (P < 0.001 C vs BN and P = 0.001 B vs BN) and (d) neurons (P = 
0.035 C vs BN and P = 0.0230 B vs BN) that contain ≥ 4 foci. All values are: means ± SEM from 
three independent experiments. One Way ANOVA, with Newman Keuls post hoc test. (e) 
Immunocytochemistry for γ-H2AX foci in differentiated NPCs with neurons identified using TUJ1. 
Representative image from three independent experiments. Dashed arrow indicates a neuron with 
	 25	
γ-H2AX foci while solid arrows show cells not immunostained for TUJ1 have increased levels of γ-
H2AX foci. Scale bar = 50 μm. 
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Figure 4: Mechanism of NP induced indirect toxicity is dependent on the presence of 
astrocytes and is triggered by autophagy in the BeWo barrier.  
(a) Immunocytochemistry of primary neuronal cultures for GFAP and TUJ1 showing near pure 
TUJ1+ve neuronal cultures are formed from dissociated fetal tissue. Representative image from 
three independent experiments. Scale bar = 100 μm. (b) Graph of the number of γ-H2AX foci in 
primary neuron cultures. One way ANOVA, F= 0.2, P = 0.85. (c) γ-H2AX foci in primary neuronal 
cultures exposed to media conditioned on astrocytes One way ANOVA F= 63, P = 0.0001. 
Neumann Keuls post hoc P = 0.0001 C vs BN and P = 0.0003 B vs BN. (d) Indirect NP toxicity 
does not influence the formation of neuroectoderm during the differentiation of embryoid bodies. 
Samples were analyzed by qPCR, using 50ng of cDNA, for a panel of genes for regional identity. 
Data from three independent experiments was analysed by one way ANOVA: OCT4; F=0.1130, P 
= 0.8950; NESTIN F= 0.1232, P = 0.8862; GATA4 F= 0.0030, P = 0.9970; EOMES F= 0.6549, P = 
0.5530; HAND1 F= 0.9105, P = 0.4515; P53, F= 0.0044, P = 0.9956. (e) Levels of IL-6 are 
increased in cultures of NPC derived astrocytes following exposure to NP conditioned media from 
the BeWo barrier. Data from three independent experiments was analysed by one way ANOVA: F= 
566.1, P <0.0001. Neumann Keuls post hoc P < 0.0001 C vs N and C vs BN;  P = 0.001 C vs B 
and B vs BN. (f) shRNA knock down of IL-6 production by the BeWo barrier significantly reduces 
the number of γ-H2AX foci in astrocytes. Data from three independent experiments was analysed 
by one way ANOVA: F=62.27; ***P< 0.0001. Neumann Kuels post hoc P < 0.0001 BN and BN+Sh 
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Ctrl vs BN+Sh-IL-6 205 and BN+Sh-IL-6 206. ** P = 0.0055 BN+Sh-IL-6-206 versus B+SH-IL-6 
206 (g) Anti-IL-6 antibody blockade in conditioned media significantly reduces the number of γ-
H2AX foci in astrocytes, while relevant IgG had no effect. Data from three independent 
experiments was analysed by one way ANOVA:  F= 33.99. P<0.0001.  
Neuman Keuls post hoc P=0.0004 BN vs BN+anti-IL-6 and P=0.0006 BN+IgG vs BN+anti-IL-6 (h) 
Autophagy inhibition in BeWo cells exposed to NPs reduces the number of γ-H2AX foci in 
astrocytes in mixed cultures.  
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Figure 5. GFAP and γ-H2AX levels are increased in the hippocampus of neonates following 
maternal exposure to CoCr NPs at E12.5. 
 (a) GFAP gene expression is increased the brains of neonates following maternal CoCr NP 
administration at E12.5 but not at E9.5. Data from three independent animals was analysed by 2-
way ANOVA, CoCr treatment effect F=6.120; P=0.03 and age effect F=5.409; P=0.048. (b) 
quantification of GFAP using corrected total cell fluorescence (CTCF) demonstrates greater GFAP 
expression in the hippocampus following NPs exposure at E12.5. P= 0.0191; unpaired t-test, two 
tailed (c) immunocytochemistry image of the hippocampus of saline control showing negligible 
GFAP staining. (d) immunocytochemistry image of the hippocampus in NP exposed group at E12.5 
showing increased GFAP staining. Representative images from three independent animals (Scale 
bars = 100 μm) (e) STEAP4 gene expression is increased in the hippocampus following maternal 
exposure to NPs at E12.5. Data from three independent animals, P= 0.0206; unpaired t-test, two 
tailed (f) quantification of γ-H2AX in the hippocampus demonstrates a greater number of foci 
following exposure to NPs at E12.5. Data from three to five independent animals was analysed by 
2-way ANOVA with Bonferroni post hoc: CoCr treatment effect F=14.13; P=0.0032 and age effect 
F=5.878; P=0.0337.  
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Supplementary Figures 
 
 
 
Supplementary Figure 1: Mitochondrial activity in the BeWo barrier following CoCr NP 
exposure. A decrease in MTS reducing activity was found following the exposure of BeWo 
barriers to CoCr NPs (BN) for 24 hours. Results are from three independent experiments and were 
analysed using an unpaired student’s T test, two tailed. Data are normalised to the barrier only 
control (B). All values are: means ± sem from three independent experiments. ** P = 0.0064.  
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Supplementary Figure 2: BeWo barrier media transfer model with neural progenitor cells  
 
BeWo cells, a human trophoblast choriocarcinoma derived cell line, were grown on transwell 
inserts for 7 days so as to form confluent bilayered cell barriers used to model the placental barrier 
in vitro (Figure 1a) (Bhabra et al., 2009; Sood et al., 2011; Parry et al., 2010; Bode et al., 2006). 
After 7 days the barriers were checked for barrier integrity, TEER measurements shown in (Figure 
1b), then 0.04mg/ml of CoCr NPs were applied to the upper layer. Neural progenitor cell media 
was placed beneath the barrier in the lower chamber and conditioned for 24 hours. This was then 
placed onto the dissociated neural progenitor cells. These had been dissociated and allowed to 
commence differentiating for 24 hours prior to exposure. These cells were then cultured in the 
transferred media for 6 days before the differentiated neuroprogenitor cells were assessed. 
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Supplementary Figure 3: The proportion of neurons and astrocytes formed from 
dissociated NPCs following indirect exposure to CoCr NPs.  
(a) Immunostaining of differentiated NPCs for GFAP and TUJ1 with scale bar 50 μm. 
Representative image from three independent experiments (b) Graph of cell counts for GFAP+ 
astrocytes and TUJ1+ neurons showing no barrier control (C), Barrier only control (B) and Barrier 
with CoCr NP exposure (BN). All values are: means + SEM from three independent experiments. 
Statistical analysis compares percentage of neurons by one way ANOVA with Newman Keuls post 
hoc test.  NS = P ≥ 0.05, C v BN P = 0.0426.	  
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Supplementary Figure 4: Viability of neural progenitor cells following indirect exposure to 
CoCr NPs. (a) Graph of Live Dead cells counts across exposure conditions assessed on day 7 of 
differentiation demonstrating no difference was found. P=0.5751 (b) Graph of MTS reducing 
activity also showing no difference between conditions. P=0.2881 All values are: means ± sem 
from three independent experiments. Data is normalised to control and no significant difference 
was found on ANOVA. (c) Live Dead cell image of BN exposed NPCs. Representative image of 
three independent experiments yielding similar results. Scale bar 50 μm.  
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Supplementary Figure 5: Dissociated NPCs differentiate to form neurons and astrocytes. 
Representative image of three independent experiments yielding similar results. These images 
demonstrate co-staining of GFAP+ cells with EAAT1. Scale bar is 50 μm. 
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Supplementary Figure 6: Increased gene expression of GFAP did not occur in 
differentiated neuroprogenitors following CoCr NP exposure to the BeWo barrier. 
Samples from differentiated neuroprogenitor cells were analyzed for GFAP expression by qPCR, 
using 50ng of cDNA. All values are: means ± sem from three independent experiments. *P < 
0.0408 by ANOVA and Newman Keuls post hoc test.  
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Supplementary Figure 7: TiO2 NPs exposure to BeWo barriers results in an increase in the 
number of γ-H2AX foci in astrocytes. 
Graph showing the percentage of astrocytes that contain ≥ 4 foci. All values are: means ± sem 
from three independent experiments. **** = P < 0.0001 by ANOVA and Newman Keuls post hoc 
test. 
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Supplementary Figure 8: F127 NP exposure to BeWo barriers does not result in an increase 
in the number of γ-H2AX foci in astrocytes. 
Graph showing the percentage of astrocytes that contain ≥ 4 foci. All values are: means ± sem 
from three independent experiments. P = 0.1010; NS by ANOVA. 
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Supplementary Figure 9: Determination of glutathione levels in NPC cultures following 
indirect exposure to NPs. Graph of glutathione induced luminescence showing increased 
glutathione levels in NPCs differentiated in BN media. All values are: means ± sem from six 
independent experiments.  **** = P < 0.0001 by ANOVA and Newman Keuls post hoc test. 
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. 
Supplementary Figure 10: Flow cytometry assessment of NSC markers Nestin and Sox1 in 
exposed embryoid bodies. 
(a) The gating strategy was forward and side scatter (using a gate that was applied to all samples), 
followed by (b) analysis of median fluorescence for AF488 Nestin (green) and Cy5 Sox1 (blue). (c) 
Indirect NP toxicity does not affect the formation of neuroectoderm during the differentiation of 
embryoid bodies. Data shown is from one representative experiment from three independent 
experiments.  
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Supplementary Figure 11: TNFα levels in media conditioned beneath the BeWo Barrier 
TNFα levels assessed by enzyme-linked immunosorbent assay found no increased expression 
following CoCr NP exposure. All values are: means ± sem from three independent experiments. P 
= 0.6163; NS by unpaired T test, two tailed. 
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Supplementary Figure 12: IL-6 was released from BeWo barriers following the exposure of 
NPs. 
 
IL-6 levels assessed by enzyme-linked immunosorbent assay were found to be significantly 
increased following CoCr NP exposure. All values are: means ± sem from three independent 
experiments. *  P = 0.041 by unpaired T test, two tailed. 
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Supplementary Figure 13: TEER values of BeWo barriers following transduction of IL-6 sh-
RNA using a lentiviral vector. 
BeWo barriers were either transduced with shRNA lentiviral particles (or not transduced as a 
control). PLKO1 non-targeting shRNA (Sigma), or IL6 shRNAs TRCN0000059205 or 
TRCN0000059206 (Sigma), were added above and below the barrier BEWO media. TEER 
measurements were not found to be significantly altered following these exposures and similar 
TEER levels were achieved as in BeWo barriers not exposed to lentiviral vectors (See Figure 1b 
for comparison). All values are: means ± sem from three independent experiments. P=0.5320; NS 
by two way - ANOVA.  
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Supplementary Figure 14: Levels	of	IL-6	are	increased	following	exposure	of	
nanoparticles	to	the	BeWo	barrier,	addition	of	an	IL-6	shRNA	reduces	the	level	of	IL-6	
to	control	levels.			
BeWo barriers were either transduced with shRNA lentiviral particles (or not transduced as a 
control). PLKO1 non-targeting shRNA (Sigma), or IL6 shRNAs TRCN0000059205 or 
TRCN0000059206 (Sigma), were added above and below the barrier BEWO media. Addition	of	an	IL-6	shRNA	reduces	the	level	of	IL-6;	shRNA	control	has	no	effect	(Data	presented	as	mean	+	SEM	of	n=4	independent	experiments).	One	way	ANOVA	plus	Neuman	Keuls	post	hoc	test.		****	P	<	0.0001	BN	and	BN+Sh	control	vs	BN+Sh	IL-6	205	and	BN+Sh	IL-6	206.	B	is	barrier	only;	BN	is	barrier	with	nanoparticles.		 	
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Supplementary Figure 15: Levels	of	γ-H2AX	are	increased	in	non-GFAP+	cells	following	
exposure	of	nanoparticles	to	the	BeWo	barrier,	then	reduced	to	control	levels	following	
the	addition	of	an	IL-6	shRNA.	
	
BeWo barriers were either transduced with shRNA lentiviral particles (or not transduced as a 
control). PLKO1 non-targeting shRNA (Sigma), or IL6 shRNAs TRCN0000059205 or 
TRCN0000059206 (Sigma), were added above and below the barrier BEWO media. This 
significantly reduced the number of γ-H2AX foci in non-GFAP positive cells; based on Suppl Figure 
3 these are considered likely to be neurons (n=3). Data	presented	as	mean	+	SEM	of	n=3	independent	experiments).	One	way	ANOVA	plus	Neuman	Keuls	post	hoc	test.		****	P	<	0.0001	
Sh-IL6 
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BN	and	BN+Sh	ctrl	vs	BN+Sh	IL-6	205	and	BN+Sh	IL-6	206.	B	is	barrier	only;	BN	is	barrier	with	nanoparticles.		
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Supplementary Figure 16. Levels	of	IL-6	are	increased	following	exposure	of	
nanoparticles	to	the	BeWo	barrier,	addition	of	an	IL-6	blocking	antibody	reduces	the	
level	of	IL-6.		IgG	control	has	no	effect	(n=3	independent	experiments).	Data	presented	as	mean	+	SEM	of	n=3	independent	experiments).	One	way	ANOVA	plus	Neuman	Keuls	post	hoc	test.	**	P	=	0.0040	B	vs	B+a-IL-6	Block	and	P	=0.0082	B+IgG	vs	B+a-IL-6	Block.		****	P	<	0.0001	BN+a-IL-6	Block	versus	BN	and	BN	+	IgG	control	antibody.	B	is	barrier	only;	BN	is	barrier	with	nanoparticles.	
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Supplementary Figure 17: TEER values of BeWo barriers following inhibition of autophagic 
degradation using a lentiviral vector containing human ATG4BC74A 
BeWo barriers were either transduced with lentiviral vectors containing GFP or GFP- ATG4BC74A. 
These were then exposed to media containing CoCr NPs or media only. TEER measurements 
were not found to be significantly altered following these exposures and similar TEER levels were 
achieved as in BeWo barriers not exposed to lentiviral vectors (See Figure 1b for comparison). All 
values are: means ± sem from three independent experiments. P= 0.9761; NS by two way - 
ANOVA.  
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Supplementary Figure 18: IL-6 secretion from the BeWo barriers exposed to NPs in the 
presence of ATG4BC74A released less IL-6 than control GFP-expressing barriers.  
Measured by enzyme-linked immunosorbent assay. Means with SEM from three independent 
experiments assessed by One way ANOVA with Neuman Keuls post hoc test. Significance Values: 
* P = 0.0370  versus BN+GFP; ** P = 0.0022  and *** P = 0.0001 versus B+GFP and B+ATG4Bc74A 
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Supplementary Figure 19: IL-6 secretion from the BeWo barriers exposed to NPs in the 
presence of BafA1 also secreted significantly less IL-6 than barriers exposed to NPs in the 
absence of BafA1.  
Measured by enzyme-linked immunosorbent assay. Means with sem of three independent 
experiments assessed by One  way ANOVA with Neuman Keuls post hoc test. Significance values: 
* P= 0.05 versus B; $$ P = 0.0058vs B+Baf and P = 0.0036 vs BN; ** P = 0.0036 versus B; *** 
P≤0.001 versus B+Baf. 
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Supplementary Figure 20: Expression of the astrocytic activation markers (a) STEAP4 and 
(b) PTX3 did not alter significantly at either time-point of NP exposure in whole brain when 
compared to relevant control groups. 
Gene expression assessment performed by qPCR relative to GAPDH expression. All values are: 
means ± sem from three independent experiments.  NS by Two way - ANOVA. (a) P =  0.3345 for 
CoCr treatment and P = 0.6729 for E9.5 vs E12.5; (b) P = 0.7631 for CoCr treatment and P = 
0.6402 for E9.5 vs E12.5.   
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Supplementary Figure 21: Levels of PTX3 gene expression were not increased in the 
hippocampus following NP exposure at E12.5. 
 
Gene expression assessment performed by qPCR. All values are: means ± sem from three 
independent experiments. P = 0.9785; NS by unpaired t test, two tailed. 
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Supplementary Figure 22: Immunohistological staining for y-H2AX demonstrated 
significantly increased DNA damage in the hippocampus in E12.5 treated animals only 
compared to relevant controls 
 
This demonstrate that increased y-H2AX immunostaining (white arrows) was present in the 
hippocampus of mice at E12.5 following maternal exposure to CoCr NPs. Representative image 
from four independent animals yielding similar results.  Scale bar is 50 μm. 
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Supplementary methods  
 
Preparation of nanoparticles 
The 80 ± 14.6 nm CoCr NPs used were produced by a thermal plasma method (Raghunathan et 
al., 2013). They were polydisperse in size measuring 80 ± 14.6 nm with a smooth outline with 
some straight edges on transmission electron microscopy using a Jeol 1200EXmkII TEM operated 
at 120 keV. They had a mean electrophoretic mobility at 25oC of -0.816 μ o−1/Vcm−1 and a mean 
zeta potential of -13mv measured on Malvern Instruments Zetasizer Nano Z equipment. In media 
they have a tendency to aggregate demonstrated by a photon correlation spectroscopy 
measurement of 241nm in media carried out on a Brookhaven instrument and release 
predominantly Co ions (Raghunathan et al., 2013).  
 
The NPs were prepared for use in tissue culture by being: placed in glass universals, weighed then 
washed with 100% ethanol. They were then heat sterilized at 180oC for 3 hours then resuspended 
in serum free growth media by sonication with 7 pulses each of 2 seconds long using a titanium 
probe and Sonics VibraCELL VC130PB sonicator (maximum output power: 130W). The metal NP 
exposures were expressed in mg/ml, this equates to 0.036 mg per cm2 surface area of BeWo 
barrier. This was calculated from the mass of the NPs before addition of media in relation to the 
surface area of the Transwell insert on which the BeWo cells were grown. The surface area of the 
Transwell insert used in all the experiments was 1.12 cm2.This exposure level has previously been 
found not to cause transition of CoCr NPs across the BeWo barrier (Bhabra et al., 2009; Parry et 
al., 2010; Sood et al., 2011).  
TiO2 NPs used for comparison to CoCr NPs were 50 nm ± 20 nm (Sood et al., 2011). 5% F127 
NPs were kindly donated by Dr Bienemann from the University of Bristol and setup as previously 
described (Basak and Bandyopadhyay, 2013; Liu et al., 2016). 
 
Supplementary Table 1: Composition of CoCr alloy (Raghunathan et al., 2013). 
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Element C Co Cr Fe Mn Mo N Ni Si 
Wt% 0.06 64.3 28.0 0.25 0.50 6.00 0.20 0.20 0.50 
Atomic% 0.29 62.5 30.8 0.26 0.52 3.58 0.82 0.20 1.02 
  
 
Transduction of BeWo barriers with IL-6 sh-RNA lentivirus. 
Bewo cells were grown on transwell inserts for 7 days to form confluent bilayered layers of the 
cells. They were seeded at 105 cells/cm2 on transwell inserts (Appleton Woods, Birmingham, UK) 
in Dulbecco’s Modified Eagle’s Nutrient Mixture (DMEM)/ F12 Ham, supplemented with 1% L-
Glutamine-Penicillin-Streptomycin, 1% amphtotericin B solution and 10% FBS. On the fifth day 
after plating of BeWo cells onto the transwell, cells were transduced with shRNA lentiviral particles 
(or not transduced as a control). PLKO1 non-targeting shRNA (Sigma), or IL6 shRNAs 
TRCN0000059205 or TRCN0000059206 (Sigma), were added above and below the barrier BEWO 
media. After two days, media was removed and nanoparticles were added: pre-prepared 
nanoparticles were thawed and  sonicated (bath sonicator) for 30 minutes. Media under the barrier 
was replaced with neuroprogenitor media comprising: 72% DMEM high glucose (Sigma), 24% 
DMEM/F12 + Glutamax (Thermo Fisher), 1% Glutamax (Thermo Fisher), 1% 
Penicillin/Streptomycin (Sigma) and 1% B27 (Thermo Fisher). 500µl of nanoparticles was added to 
the top of the barrier (or BEWO media without serum as a control). The following day, 
transepithelial/transendothelial electrical resistance (TEER) measurements were taken in the 
media on top of the barrier. Then, the media under the barrier was collected and snap-frozen in 
liquid nitrogen. 
To study the effects on NPC differentiation from the conditioned media neurospheres were 
dissociated using accutase (Sigma) then placed in media without mitogens. 1 x 105 cells were then 
seeded onto 13mm PDL/laminin coated glass coverslips and allowed to adhere for 24 hours after 
which their media was replaced with NPC differentiation media conditioned in the BeWo barrier 
model plus/minus IL-6 shRNAs then cultured until day 7 of differentiation.  
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IL-6 antibody blocking experiment. 
 
In another set of experiments BeWo barrier conditioned media was added to the cells, together 
with an anti-IL-6 antibody or relevant IgG control, at a concentration of 0.15 ug/ml (R&D systems). 
The blocking antibody remained in the culture for 6 days prior to removal of the media for 
measurement of IL-6 or fixation with 4% PFA for immunohistochemistry.  
 
 
 
BeWo barrier immunoblot 
Cells were lysed in RIPA buffer plus protease inhibitor (Roche). Protein was quantified using a 
BCA assay (Thermo Scientific) and resolved on polyacrylamide SDS-Tris-Glycine gels. Proteins 
were transferred onto PVDF membrane (Roche) and blocked using 10% non-fat milk in 0.1% TBS-
T (Sigma). Incubation with primary antibody (mouse anti-HSP70 (Stressgen ♯C92F3A) 1:1000, 
mouse anti-p62 (Abnova ♯ H00008878-M01) 1:1000, mouse anti-p53 (Cell Signalling ♯2524) 
1:1000, rabbit anti-LC3 (MBL ♯PM036) 1:1000, mouse anti-α-Tubulin (Sigma ♯T5168) 1:10,000) 
was carried out overnight at 4 °C in blocking buffer. Membranes were incubated with the 
appropriate HRP-labelled secondary antibody for 2 h at room temperature. Protein bands were 
visualized using Pierce Plus Substrate (Thermo). 
 
Immunocytochemistry in NPCs 
Cells were fixed in 4% paraformaldehyde (Fisher), with the exception of BeWo barrier staining 
where cells were fixed with ice cold 100% methanol. Cells were blocked at room temperature in 
PBS/10% goat serum/Triton X-100 0.1%. Primary antibodies were incubated overnight at 4 °C in 
PBS/2% goat serum/Triton X-100 0.1% using mouse anti-TUJ1 (Covance ♯MMS-435P) 1:1000, 
rabbit anti-GFAP (Dako ♯Z0334, Lot 20015408) 1:1000, chicken anti-GFAP (Abcam ♯Ab4674, Lot 
2670366 ) 1:2000, rabbit anti-phosphorylated H2A.X (Ser139) (Cell Signalling Technology, ♯9718) 
rabbit anti-EAAT1 (Novus Biologicals NBP1-20135) 1:200, mouse anti-SQSTM1 (Abnova 
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♯H00008878-M01) 1:500 and rabbit anti-LC3-II (Viva ♯VB2930) 1:300. Alexa Fluor (Life Tech) 
secondary antibodies were incubated at room temperature for 2 hours in PBS/1% goat 
serum/Triton X-100. Cells were co-stained with DAPI (Sigma) and mounted in Vectorshield 
(Vectorlabs). Images were taken using fluorescence Leica DM RB upright microscope and 
processed using Adobe Photoshop and Image J software.  
 
GSH-Glo Glutathione Assay in NPCs 
The GSH-Glo luminescent assay (Promega) was used to detect the amount of GSH in exposed 
NPC cells and was measured on a Promax glomax multi detection system. 
 
Live Dead Cell Count in NPCs 
The Live/Dead viability/cytotoxicity kit (Life Technologies) was used to determine the number of live 
cells in the NPC cultures post media transfer experiments. The number of live and dead NPC cells 
on coverslips was counted using a Leica DMRB (Leitz) fluorescence microscope and image J. 
 
MTS Cell Proliferation Assay in NPCs 
The CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (Promega) was used to 
determine the mitochondrial activity in NPC cells and was measured on a Promega glomax multi 
detection system. 
 
Assessment of GFAP gene expression in differentiated NPCs 
Total RNA was extracted from cells (RNeasy mini system, Qiagen) and treated with RNase-free 
DNase I (Roche). cDNA was generated using Multiscribe reverse transcriptase (Thermo) and then 
a pre-amplification step was carried out using Taqman PreAmp mastermix and gene specific 
primers (Thermo). qPCR was carried out using the Taqman Universal Master Mix and Taqman 
assays (Thermo). Applied Biosystems software was used for analysis and relative gene fold 
variations were compared to the values for GAPDH that acted as a housekeeping gene.  
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Assessment of gene expression in embryoid bodies by qPCR 
Embryoid Bodies (EBs) were created from Shef3 hES cells and allowed to expand in culture for 4 
days. Following this the EB media was removed and replaced with EB media conditioned under 
the BeWo barrier model. The EBs were removed from this on day 7 then total RNA was extracted. 
(RNeasy mini system, Qiagen), treated DNase I (Roche). cDNA was generated using Multiscribe 
reverse transcriptase (Thermo) and the qPCR was carried out using the Taqman Universal Master 
Mix and Taqman assays. Each 20μl a reaction contained 50 ng cDNA. Applied Biosystems 
software was used for analysis and relative gene fold variations were compared to the values for 
GAPDH that acted as a housekeeping gene.  
 
 
Supplementary Table 2: Taqman gene expression assays  
 
Gene Taqman Assay ID 
EOMES Hs00172872_m1 
GAPDH Hs00266705_g1/Hs02758991_g1 
GATA4 Hs00171403_m1 
GFAP Hs00909233_m1 
HAND1 Hs02330376_s1 
NESTIN Hs00707120_s1 
OCT 4 Hs03005111_g1 
P53 Hs01034249_m1 
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Assessment of Embryoid Bodies by flow cytometry  
 
Flow cytometry was used to assess the formation of the three germ layers from 
embryoid bodies (EBs). EBs were harvested following media transfer exposure 
on day 7 of expansion and dissociated using Accutase. Dissociated cells were then washed with 
DPBS then fixed in 4% PFA. 10% NGS diluted in 0.1% PBS-Triton X100 was used for blocking. 
Control samples were run for all primary and secondary antibodies prior to flow cytometry 
assessment to check for cross reactivity and to determine levels of autofluorescence. Primary 
antibodies used were 1:4000 Goat anti chicken SOX1 (Millipore AB5934) and 1:20 Goat anti 
mouse Nestin (Abcam AB6320). Secondary antibodies used were 1:2000 Cy5 anti chicken (Abcam 
AB97147) and 1:500 Alexa fluor 488 anti mouse IgG (Life Tech A11001). Flow cytometry 
assessment was performed on a BD LSR Fortessa X20 using FlowJo software. The authors wish 
to acknowledge the assistance of Dr. Andrew Herman and Sally Chappell and the University of 
Bristol Faculty of Biomedical Sciences Flow Cytometry Facility. 
 
ELISA 
Analysis of IL-6, TNFα, RANTES and GM-CSF concentrations 
Supernatant concentrations of IL-6, TNFa, RANTES and GM-CSF (all from R&D Systems), 
obtained from BeWo barriers +/- nanoparticles or from astrocyte cultures +/- media conditioned by 
the BeWo barrier were measured using ELISA. Cytokine / chemokine concentrations in the test 
samples were evaluated with reference to the standard curves prepared using recombinant 
cytokines of a known concentration. 
 
Additional mouse in vivo methods 
Immunofluorescence staining and analysis 
Frozen sections were incubated in blocking solution containing 10% goat serum (Invitrogen) in 
0.3% PBS-Triton X-100 (Sigma-Aldrich) at room temperature for 2 hours. Sections were stained 
with primary antibody, Polyclonal Chicken Anti-GFAP (1:500 Abcam ♯Ab4674) or rabbit anti-
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phosphorylated H2A.X (Ser139) (Cell Signalling Technology, ♯9718) (1:500) diluted in 2% goat 
serum in PBS-Triton X-100 and incubated at 4oC overnight. The sections were rinsed and washed 
(3x for 10min) in PBS and Triton X-100. Secondary antibody using Life Technology Alexa Fluor 
488 Goat anti-chicken 1:500 dilution or Alexa Fluor 555 Goat anti-rabbit 1:500 dilution was 
incubated for 2 hours at room temperature. Following wash steps, sections were mounted with 
Vectashield mounting medium containing DAPI (Vector Laboratories) and coverslips applied. 
 
GFAP immunofluorescence intensity was analysed using Image J software (NIH, Betheseda, US) 
in sagittal sections (20mm) in the hippocampal region of P0 mouse brains. Sections were imaged 
with a Zeiss Fluorescent microscope (Axio Imager Z1) using 20x/0.5Ph2 objective lens, connected 
to an Axiocam HRm camera powered by AxioVision software. Captured digital images were 
analysed using Image J software as described by (Karve et al., 2016; McCloy et al., 2014) 
whereby regions of interest (ROIs) containing GFAP positive fluorescing cells were traced, which 
measured selected areas and integrated densities. The corrected total cell fluorescence (CTCF) 
intensities were determined by subtracting the area of selected GFAP positive cells multiplied by 
the mean fluorescence of background readings from the integrated density of cells. CTCF = 
Integrated Density–(Area of selected cell x Mean fluorescence of background readings). Average 
CTCF values were calculated for 10 x GFAP positive cells and 5 x background levels in the 
hippocampal region of P0 mouse brains sections from each treatment group (3 sections per slide 
and 3 slides per animal). For quantification of γ-H2AX immunostained sections were viewed under 
a 63x objective lens on a Zeiss Aim-system confocal microscope. Within the area of the 
hippocampus each cell containing 4 or more foci was considered damaged and hence counted.  
 
qPCR quantitation of STEAP4, GFAP and PTX3 mRNA expression in P0 whole mouse brain 
and hippocampus.  
RNA was isolated using the NucleoSpin RNA II kit (Machery Nagel, UK) as per the manufacturer's 
instructions. Extracted RNA yield was quantified using a NanoDrop’ND-1000 UV-Vis 
spectrophotometer (Thermo Fisher Scientific, UK) and cDNA was synthesised using a High 
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Capacity cDNA archive kit (Applied Biosystems, UK). Analysis of gene expression was conducted 
using real time PCR with specific primer and probe sets (Applied Biosystems).  
 
In order to quantify the expression of specific target genes of interest, samples were assayed in 
duplicate with either primers and probes for GAPDH and PTX3 with FastStart Universal Probe 
Master mix (Roche) or primers (STEAP4 and GFAP) with FastStart Universal Sybr Green Master 
mix (Roche). Quantitative real-time PCR reactions were performed in a StepOne Plus™Real-Time 
PCR system (Applied Biosystems, UK) using the following cycling protocol: 95oC for 10min; 95oC 
for 10s and 60oC for 30s for 40 cycles.  
 
Gene expression analysis was conducted by the relative quantitation method with cDNA 
synthesized from an LPS injected mouse brain, which was utilized as the standard that would 
induce expression of all target genes of interest. Following subsequent dilutions, a linear standard 
curve was created whereby cycle threshold (Ct) was relative to concentrations of transcripts to 
determine relative mRNA expression, as previously described by (Hennessy et al., 2015; 
Cunningham et al., 2005). GAPDH was used as the endogenous control gene and target genes of 
interest were standardised to GAPDH.  
 
Supplementary Table 3: The sequences for the primers and probes for the qPCR in vivo 
mouse experiments. 
 
Gene Forward Primer Reverse Primer 
GFAP CTCCAACCTCCAGATCCGAG TCCACAGTCTTTACCAGATGT 
STEAP4 TGCAAGCCGGCAGGTGTTTGT TCCAGTGGGGTGAGCCCAAGA 
PTX3 ACAACGAAATAGACAATGGACTTCAT CTGGCGGCAGTCGCA; Probe, 
CCACCGAGGACCCCACGCC 
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